Health and Fitness Health and Fitness
Tue, February 24, 2009
Mon, February 23, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
Amedisys to Host Investor Day
Sun, February 22, 2009
Fri, February 20, 2009
Thu, February 19, 2009
[ Thu, Feb 19th 2009 ] - Market Wire
Enzon Reports 2008 Results
Wed, February 18, 2009
Tue, February 17, 2009
Mon, February 16, 2009
Fri, February 13, 2009
Thu, February 12, 2009
Wed, February 11, 2009
Tue, February 10, 2009
Mon, February 9, 2009
Sun, February 8, 2009
Fri, February 6, 2009
Thu, February 5, 2009

Noven to Present at Roth 21ST Annual Growth Stock Conference


//health-fitness.news-articles.net/content/2009/ .. at-roth-21st-annual-growth-stock-conference.html
Published in Health and Fitness on Thursday, February 12th 2009 at 14:24 GMT, Last Modified on 2009-02-12 14:24:42 by Market Wire   Print publication without navigation


MIAMI--([ BUSINESS WIRE ])--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that it is scheduled to present an update on its business and prospects at the Roth 21st Annual OC Growth Stock Conference in California on Tuesday, February 17th at 11:00 a.m. PST (2:00 p.m. EST). The presentation will be webcast live at [ www.noven.com ], and a rebroadcast will be available thereafter for at least two weeks at the same site.

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. Noven's business and operations are focused in three principal areas – transdermal drug delivery, the Novogyne joint venture, and Noven Therapeutics, Noven's specialty pharmaceutical unit. For more information about Noven Pharmaceuticals, visit [ www.noven.com ].


Publication Contributing Sources